Security key
77313F106
ROCKET PHARMACEUTICALS, INC. - Common Stock (RCKT)
CUSIP: 77313F106
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 94,974,795
- Total 13F value
- $232,855,173
- Share change
- -13,115,545
- Put/Call ratio
- 94%
- SEC-reported price per share
- $2.45
- Number of holders
- 194
- Value change
- -$147,581,517
- Number of buys
- 120
- Number of sells
- 126
- Shares outstanding
- 109,265,652
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
194
Top holders
10
RCKT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
ROCKET PHARMACEUTICALS, INC. SEC filings
ROCKET PHARMACEUTICALS, INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 77313F106
Recent filing periods:
Ownership snapshot
Top reported holders of RCKT - ROCKET PHARMACEUTICALS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
WELLINGTON MANAGEMENT GRO...
Disclosed value leader
WELLINGTON MANAGEMENT GRO...
Comparable rows
15/15
Latest evidence
18 Jun 2025
13F
13D/G
3/4/5
Lead comparable stake: 0.9%
13D/G row: WELLINGTON MANAGEMENT GROUP LLP
Showing 1-6 of 15 holder rows.
Quick read
WELLINGTON MANAGEMENT GROUP LLP leads the comparable SEC ownership view at 0.9%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens WELLINGTON MANAGEMENT GROUP LLP's linked filing trail.
Comparable ownership
Top 5
WELLINGTON MANAGEMENT GROUP LLP
0.9%
Roderick Wong
17%
David P. Southwell
0.13%
Pedro P. Granadillo
0.05%
Carsten Boess
0.03%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
Company
|
0.9%
from 13D/G
|
$84,218,695
12,626,491 shares
|
— | 31 Mar 2025 |
| Roderick Wong |
3/4/5
Director, 10%+ Owner
|
17%
|
$44,689,444
18,236,124 shares
|
— | 18 Jun 2025 |
| David P. Southwell |
3/4/5
Director
|
0.13%
|
$354,806
144,784 shares
|
— | 18 Jun 2025 |
| Pedro P. Granadillo |
3/4/5
Director
|
0.05%
|
$134,131
54,734 shares
|
— | 18 Jun 2025 |
| Carsten Boess |
3/4/5
Director
|
0.03%
|
$73,518
30,000 shares
|
— | 18 Jun 2025 |
| Fady Ibraham Malik |
3/4/5
Director
|
0.03%
|
$73,518
30,000 shares
|
— | 18 Jun 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
194
Shares
94,974,795
Rows available
194
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
233
Q2 2025 holders
194
Holder diff
-39
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend